Analysis of the Extent of Liver Oncological Extended Resection for Incidental Gallbladder Cancer: How Much Is Too Much?
- PMID: 37460736
- DOI: 10.1245/s10434-023-13861-1
Analysis of the Extent of Liver Oncological Extended Resection for Incidental Gallbladder Cancer: How Much Is Too Much?
Abstract
Background: Liver resection is pivotal in treating incidental gallbladder cancer (IGBC). However, the adequate volume of liver resection remains controversial.
Methods: A cross-sectional retrospective analysis was performed on resected IGBC patients between 1999 and 2018. Morbidity was evaluated according to the Clavien-Dindo classification. The theoretical volume of a 2-cm and 1.5-cm wedge liver resection was calculated (105 cm3 and 77.5 cm3, respectively) and used as reference. Overall survival (OS) was estimated using Kaplan-Meier and Cox regression analyses.
Results: Among 111 patients re-resected for IGBC, 84 provided sufficient data to calculate liver resection volume. Patients with a resection volume ≥ 105 cm3 had a higher rate of overall morbidity (P = 0.001) and length of stay (P = 0.012), with no difference in mortality. There was no significant difference in OS according to residual cancer or T-category. A resection volume ≥ 77.5 cm3 was more frequent in T ≥ 3 than in T1-2 patients (P = 0.026), and residual cancer was higher (P = 0.041) among patients with ≥ 77.5 cm3 resected. Cox multivariate regression showed that residual cancer (HR = 11.47, P < 0.001), perineural/lymphovascular invasion (HR = 2.48, P = 0.021), and Clavien-Dindo ≥ IIIa morbidity (HR = 5.03, P = 0.003) predict worse OS, but not liver volume resection.
Conclusion: There are no significant differences in OS based on resected liver volume of IGBC, when R0 is achieved. There is a significant difference in morbidity and length of stay when liver wedges are ≥ 105 cm3, which is lost when analyzed by Clavien-Dindo ≥ IIIa. A 77.5-105 cm3 resection is indicated in ≥ T3 patients, minimizing morbidity risk, while addressing concerns of overall survival.
© 2023. Society of Surgical Oncology.
Comment in
-
ASO Author Reflections: Precision in Gallbladder Cancer Care: Present Challenges and Future Directions.Ann Surg Oncol. 2023 Oct;30(11):6601-6602. doi: 10.1245/s10434-023-14062-6. Epub 2023 Aug 7. Ann Surg Oncol. 2023. PMID: 37548834 No abstract available.
Similar articles
-
Anatomic location of residual disease after initial cholecystectomy independently determines outcomes after re-resection for incidental gallbladder cancer.Langenbecks Arch Surg. 2021 Aug;406(5):1521-1532. doi: 10.1007/s00423-021-02165-1. Epub 2021 Apr 10. Langenbecks Arch Surg. 2021. PMID: 33839959
-
[Immediate radical re-resection of incidental T1b gallbladder cancer and the problem of an adequate extent of resection (results of the German Registry "Incidental Gallbladder Cancer")].Zentralbl Chir. 2014 Dec;139 Suppl 2:e43-8. doi: 10.1055/s-0030-1262698. Epub 2011 Mar 1. Zentralbl Chir. 2014. PMID: 21365537 German.
-
Laparoscopic versus open oncological extended re-resection for incidental gallbladder adenocarcinoma: we can do more than T1/2.Surg Endosc. 2023 May;37(5):3642-3656. doi: 10.1007/s00464-022-09839-x. Epub 2023 Jan 12. Surg Endosc. 2023. PMID: 36635401
-
Survival Benefit with Re-resection and Optimal Time to Re-resection in Gallbladder Cancer: a National Cancer Database Study.J Gastrointest Cancer. 2023 Dec;54(4):1331-1337. doi: 10.1007/s12029-023-00934-3. Epub 2023 May 25. J Gastrointest Cancer. 2023. PMID: 37231186 Review.
-
Residual disease in lymph nodes has no influence on survival in patients with incidental gallbladder cancer - institution experience with literature review.Radiol Oncol. 2021 Dec 22;56(2):208-215. doi: 10.2478/raon-2021-0048. Radiol Oncol. 2021. PMID: 34957726 Free PMC article. Review.
Cited by
-
New trends in diagnosis and management of gallbladder carcinoma.World J Gastrointest Oncol. 2024 Jan 15;16(1):13-29. doi: 10.4251/wjgo.v16.i1.13. World J Gastrointest Oncol. 2024. PMID: 38292841 Free PMC article. Review.
-
From open to minimally invasive: evolving surgical approach for incidental gallbladder cancer (with video).Surg Endosc. 2025 Aug 25. doi: 10.1007/s00464-025-12126-0. Online ahead of print. Surg Endosc. 2025. PMID: 40854995
-
De-escalating surgical treatment in low stage gallbladder cancer.Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):1038-1040. doi: 10.21037/hbsn-24-576. Epub 2024 Nov 14. Hepatobiliary Surg Nutr. 2024. PMID: 39669083 Free PMC article. No abstract available.
References
-
- Cherkassky L, D’Angelica M. Gallbladder cancer: managing the incidental diagnosis. Surg Oncol Clin. 2019;28(4):619–30. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical